Search

Christopher P Schwartz

Examiner (ID: 16053, Phone: (571)272-7123 , Office: P/3657 )

Most Active Art Unit
3657
Art Unit(s)
3683, 3613, 3657, 3103
Total Applications
3838
Issued Applications
3193
Pending Applications
171
Abandoned Applications
289

Applications

Application numberTitle of the applicationFiling DateStatus
Array ( [id] => 5705691 [patent_doc_number] => 20060194739 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-31 [patent_title] => 'Nociceptin-based analgesics' [patent_app_type] => utility [patent_app_number] => 11/402083 [patent_app_country] => US [patent_app_date] => 2006-04-11 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 27 [patent_figures_cnt] => 27 [patent_no_of_words] => 9604 [patent_no_of_claims] => 67 [patent_no_of_ind_claims] => 51 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0194/20060194739.pdf [firstpage_image] =>[orig_patent_app_number] => 11402083 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/402083
Nociceptin-based analgesics Apr 10, 2006 Abandoned
Array ( [id] => 823708 [patent_doc_number] => 07405199 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-29 [patent_title] => 'Cross-linked glycopeptide-cephalosporin antibiotics' [patent_app_type] => utility [patent_app_number] => 11/233220 [patent_app_country] => US [patent_app_date] => 2005-09-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17690 [patent_no_of_claims] => 6 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 6 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/405/07405199.pdf [firstpage_image] =>[orig_patent_app_number] => 11233220 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/233220
Cross-linked glycopeptide-cephalosporin antibiotics Sep 21, 2005 Issued
Array ( [id] => 5814033 [patent_doc_number] => 20060084130 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-04-20 [patent_title] => 'Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample' [patent_app_type] => utility [patent_app_number] => 11/224951 [patent_app_country] => US [patent_app_date] => 2005-09-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 13 [patent_figures_cnt] => 13 [patent_no_of_words] => 7924 [patent_no_of_claims] => 22 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0084/20060084130.pdf [firstpage_image] =>[orig_patent_app_number] => 11224951 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/224951
Method for diagnosing a transmissible spongiform subacute encephalopathy caused by an unconventional transmissible agent strain in a biological sample Sep 13, 2005 Issued
Array ( [id] => 5656450 [patent_doc_number] => 20060142186 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-06-29 [patent_title] => 'Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer\'s disease' [patent_app_type] => utility [patent_app_number] => 11/179608 [patent_app_country] => US [patent_app_date] => 2005-07-13 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4523 [patent_no_of_claims] => 18 [patent_no_of_ind_claims] => 7 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0142/20060142186.pdf [firstpage_image] =>[orig_patent_app_number] => 11179608 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/179608
Leuprolide acetate and acetylcholinesterase inhibitors or NMDA receptor antagonists for the treatment of alzheimer's disease Jul 12, 2005 Abandoned
Array ( [id] => 5821033 [patent_doc_number] => 20060025346 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-02-02 [patent_title] => 'Permeability enhancer' [patent_app_type] => utility [patent_app_number] => 11/171551 [patent_app_country] => US [patent_app_date] => 2005-07-01 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 4 [patent_figures_cnt] => 4 [patent_no_of_words] => 4400 [patent_no_of_claims] => 13 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0025/20060025346.pdf [firstpage_image] =>[orig_patent_app_number] => 11171551 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/171551
Permeability enhancer Jun 30, 2005 Abandoned
Array ( [id] => 856819 [patent_doc_number] => 07375078 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-05-20 [patent_title] => 'Heterocyclic self-immolative linkers and conjugates' [patent_app_type] => utility [patent_app_number] => 11/064785 [patent_app_country] => US [patent_app_date] => 2005-02-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 21920 [patent_no_of_claims] => 3 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 9 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/375/07375078.pdf [firstpage_image] =>[orig_patent_app_number] => 11064785 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/064785
Heterocyclic self-immolative linkers and conjugates Feb 21, 2005 Issued
Array ( [id] => 5678325 [patent_doc_number] => 20060183681 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2006-08-17 [patent_title] => 'Stabilized compositions containing natriuretic peptides' [patent_app_type] => utility [patent_app_number] => 11/058465 [patent_app_country] => US [patent_app_date] => 2005-02-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 2 [patent_no_of_words] => 4282 [patent_no_of_claims] => 29 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0183/20060183681.pdf [firstpage_image] =>[orig_patent_app_number] => 11058465 [rel_patent_id] =>[rel_patent_doc_number] =>)
11/058465
Stabilized compositions containing natriuretic peptides Feb 13, 2005 Abandoned
Array ( [id] => 7149560 [patent_doc_number] => 20050120397 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-06-02 [patent_title] => 'Compounds and methods for regulation of spermatid differentiation' [patent_app_type] => utility [patent_app_number] => 10/993167 [patent_app_country] => US [patent_app_date] => 2004-11-22 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 20 [patent_figures_cnt] => 20 [patent_no_of_words] => 19197 [patent_no_of_claims] => 79 [patent_no_of_ind_claims] => 27 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0120/20050120397.pdf [firstpage_image] =>[orig_patent_app_number] => 10993167 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/993167
Compounds and methods for regulation of spermatid differentiation Nov 21, 2004 Abandoned
Array ( [id] => 737513 [patent_doc_number] => 07033997 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-04-25 [patent_title] => 'Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections' [patent_app_type] => utility [patent_app_number] => 10/989397 [patent_app_country] => US [patent_app_date] => 2004-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 2 [patent_figures_cnt] => 4 [patent_no_of_words] => 1658 [patent_no_of_claims] => 9 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 49 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/033/07033997.pdf [firstpage_image] =>[orig_patent_app_number] => 10989397 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/989397
Use of natriuretic peptides as antibiotically active substances for the treatment of bacterial infections Nov 16, 2004 Issued
Array ( [id] => 668520 [patent_doc_number] => 07094761 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-08-22 [patent_title] => 'Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions' [patent_app_type] => utility [patent_app_number] => 10/977810 [patent_app_country] => US [patent_app_date] => 2004-10-28 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 6 [patent_figures_cnt] => 11 [patent_no_of_words] => 18833 [patent_no_of_claims] => 31 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 20 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/094/07094761.pdf [firstpage_image] =>[orig_patent_app_number] => 10977810 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/977810
Methods and compounds for prevention and treatment of elevated intraocular pressure and related conditions Oct 27, 2004 Issued
Array ( [id] => 7111676 [patent_doc_number] => 20050209132 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-09-22 [patent_title] => 'CROSS-LINKED GLYCOPEPTIDE-CEPHALOSPORIN ANTIBIOTICS' [patent_app_type] => utility [patent_app_number] => 10/967578 [patent_app_country] => US [patent_app_date] => 2004-10-18 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 17646 [patent_no_of_claims] => 28 [patent_no_of_ind_claims] => 2 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0209/20050209132.pdf [firstpage_image] =>[orig_patent_app_number] => 10967578 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/967578
Cross-linked glycopeptide-cephalosporin antibiotics Oct 17, 2004 Issued
Array ( [id] => 7609792 [patent_doc_number] => 06998397 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-02-14 [patent_title] => 'Method for decreasing cholesterol level in blood' [patent_app_type] => utility [patent_app_number] => 10/710613 [patent_app_country] => US [patent_app_date] => 2004-07-23 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 3911 [patent_no_of_claims] => 2 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 63 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/06/998/06998397.pdf [firstpage_image] =>[orig_patent_app_number] => 10710613 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/710613
Method for decreasing cholesterol level in blood Jul 22, 2004 Issued
Array ( [id] => 7056409 [patent_doc_number] => 20050277584 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2005-12-15 [patent_title] => 'Pharmaceutical compositions comprising cyclosporins' [patent_app_type] => utility [patent_app_number] => 10/865638 [patent_app_country] => US [patent_app_date] => 2004-06-09 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 2619 [patent_no_of_claims] => 24 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 0 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0277/20050277584.pdf [firstpage_image] =>[orig_patent_app_number] => 10865638 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/865638
Pharmaceutical compositions comprising cyclosporins Jun 8, 2004 Abandoned
Array ( [id] => 720161 [patent_doc_number] => 07049298 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-05-23 [patent_title] => 'Flavor-active peptides' [patent_app_type] => utility [patent_app_number] => 10/812088 [patent_app_country] => US [patent_app_date] => 2004-03-30 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 3788 [patent_no_of_claims] => 12 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 25 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/049/07049298.pdf [firstpage_image] =>[orig_patent_app_number] => 10812088 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/812088
Flavor-active peptides Mar 29, 2004 Issued
Array ( [id] => 833523 [patent_doc_number] => 07396812 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2008-07-08 [patent_title] => 'Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof' [patent_app_type] => utility [patent_app_number] => 10/551040 [patent_app_country] => US [patent_app_date] => 2004-03-29 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 9 [patent_figures_cnt] => 27 [patent_no_of_words] => 11321 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 3 [patent_words_short_claim] => 61 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/396/07396812.pdf [firstpage_image] =>[orig_patent_app_number] => 10551040 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/551040
Method for modulating Nod1 activity, use of a MTP related molecule for modulating Nod1 activity, and therapeutic applications thereof Mar 28, 2004 Issued
Array ( [id] => 7672962 [patent_doc_number] => 20040180817 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-09-16 [patent_title] => 'Neuropathologies associated with expression of tnf-$g (a)' [patent_app_type] => new [patent_app_number] => 10/473994 [patent_app_country] => US [patent_app_date] => 2004-03-03 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 3 [patent_figures_cnt] => 3 [patent_no_of_words] => 10568 [patent_no_of_claims] => 8 [patent_no_of_ind_claims] => 4 [patent_words_short_claim] => 14 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0180/20040180817.pdf [firstpage_image] =>[orig_patent_app_number] => 10473994 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/473994
Neuropathologies associated with expression of tnf-$g (a) Mar 2, 2004 Abandoned
Array ( [id] => 7261540 [patent_doc_number] => 20040241197 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-12-02 [patent_title] => 'Cosmetic or dermatological preparations including creatinine or a derivative thereof and creatine or a derivative thereof and methods of applying the preparations to the skin' [patent_app_type] => new [patent_app_number] => 10/767962 [patent_app_country] => US [patent_app_date] => 2004-01-26 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 0 [patent_figures_cnt] => 0 [patent_no_of_words] => 6498 [patent_no_of_claims] => 33 [patent_no_of_ind_claims] => 11 [patent_words_short_claim] => 44 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0241/20040241197.pdf [firstpage_image] =>[orig_patent_app_number] => 10767962 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/767962
Cosmetic or dermatological preparations including creatinine or a derivative thereof and creatine or a derivative thereof and methods of applying the preparations to the skin Jan 25, 2004 Abandoned
Array ( [id] => 655153 [patent_doc_number] => 07109291 [patent_country] => US [patent_kind] => B2 [patent_issue_date] => 2006-09-19 [patent_title] => 'Compounds capable of modulating the activity and stimulating the production of a catalytic antibody' [patent_app_type] => utility [patent_app_number] => 10/716030 [patent_app_country] => US [patent_app_date] => 2003-11-17 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 6081 [patent_no_of_claims] => 5 [patent_no_of_ind_claims] => 1 [patent_words_short_claim] => 52 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => patent [pdf_file] => patents/07/109/07109291.pdf [firstpage_image] =>[orig_patent_app_number] => 10716030 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/716030
Compounds capable of modulating the activity and stimulating the production of a catalytic antibody Nov 16, 2003 Issued
Array ( [id] => 7238248 [patent_doc_number] => 20040157772 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-08-12 [patent_title] => 'Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis' [patent_app_type] => new [patent_app_number] => 10/477775 [patent_app_country] => US [patent_app_date] => 2003-11-14 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 1 [patent_figures_cnt] => 1 [patent_no_of_words] => 3359 [patent_no_of_claims] => 15 [patent_no_of_ind_claims] => 10 [patent_words_short_claim] => 18 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0157/20040157772.pdf [firstpage_image] =>[orig_patent_app_number] => 10477775 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/477775
Use of a gatran for the manufacture of a medicament of the treatment of pulmonary fibrosis Nov 13, 2003 Abandoned
Array ( [id] => 7336696 [patent_doc_number] => 20040132642 [patent_country] => US [patent_kind] => A1 [patent_issue_date] => 2004-07-08 [patent_title] => 'Methods of inhibiting metastasis or growth of a tumor cell' [patent_app_type] => new [patent_app_number] => 10/706265 [patent_app_country] => US [patent_app_date] => 2003-11-12 [patent_effective_date] => 0000-00-00 [patent_drawing_sheets_cnt] => 5 [patent_figures_cnt] => 5 [patent_no_of_words] => 13023 [patent_no_of_claims] => 39 [patent_no_of_ind_claims] => 6 [patent_words_short_claim] => 41 [patent_maintenance] => 1 [patent_no_of_assignments] => 0 [patent_current_assignee] =>[type] => publication [pdf_file] => publications/A1/0132/20040132642.pdf [firstpage_image] =>[orig_patent_app_number] => 10706265 [rel_patent_id] =>[rel_patent_doc_number] =>)
10/706265
Methods of inhibiting metastasis or growth of a tumor cell Nov 11, 2003 Abandoned
Menu